MEDICA Trade Fair 2024 brings innovations in hemoglobin A1C testing and point-of-care diagnostics with Orange Biomed.
Our flagship product, the OBM rapid A1C device, represents a breakthrough in hemoglobin A1C testing. Designed to deliver lab-accurate results in just 5 minutes, this portable, user-friendly device is transforming the way diabetes is managed worldwide.
AI-driven skin scanners for detecting disease progression offer new possibilities for managing chronic conditions like diabetes.
Insights from wearable devices reveal how patient behavior and external factors influence glucose management.
Sensor soles designed to prevent diabetic foot ulcers demonstrate how real-time data can improve patient outcomes.
Advanced orthoses with integrated sensors provide new solutions for diabetic foot syndrome, enhancing treatment effectiveness.
These innovations highlight MEDICA’s role as a global platform for presenting transformative technologies in diabetes care.
Explore advancements in POC diagnostics that enable faster, more reliable testing.
Discover how digital tools are enhancing diabetes management through real-time monitoring and actionable insights.
Learn about trends in personalizing diabetes care to improve patient outcomes and experiences.
MEDICA continues to set the stage for groundbreaking developments in diabetes care.
For patients with diabetic foot syndrome, advanced orthoses equipped with integrated sensors are offering new hope. These devices monitor foot pressure and provide insights to prevent complications. The project, led by Prof. Dr.-Ing. Martin Kohlhase and Prof. Dr. med. Rena Isabel Amelung from Bielefeld University of Applied Sciences, represents a significant step forward in addressing one of diabetes care’s most challenging complications.
We look forward to following up with all our connections from MEDICA 2024! Fill out the form below to schedule a personalized meeting with our team and discover how our OBM rapid A1C device is transforming diabetes care.
"*" indicates required fields
If you are interested in a collaboration opportunity, email us at